Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Subhas Gupta

Plastic and Reconstructive Surgery Loma Linda, CA Medical Doctor

NPI 1659309805 CMS profile 165160

11370 Anderson St, Suite 2100, Loma Linda, CA 92354

Open in the dashboard

General payments

$178,120

280 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$26,945 paid to institutions, not to them · program years 2021–2024

Through program year 2025, Subhas Gupta of Loma Linda, CA is reported in the CMS Open Payments database as having received $178,120 across 280 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $26,945 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $94,058 73
2024 General $33,044 67
2023 General $7,437 37
2022 General $11,934 33
2021 General $10,060 17
2020 General $11,980 20
2019 General $9,607 33

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Subhas Gupta
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Subhas Gupta were reported at $94,058. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Subhas Gupta Plastic and Reconstructive Surgery median Middle half National median
2019 $9,607 $335 $121–$1,264 $163
2020 $11,980 $162 $57–$417 $114
2021 $10,060 $245 $89–$735 $132
2022 $11,934 $325 $120–$932 $149
2023 $7,437 $343 $129–$999 $160
2024 $33,044 $390 $141–$1,085 $164
2025 $94,058 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Integra LifeSciences Corporation $162,347 161 payments
  2. AbbVie, Inc. $3,686 9 payments
  3. Johnson & Johnson Health Care Systems Inc. $3,078 1 payment
  4. KCI USA, Inc $3,007 9 payments
  5. Musculoskeletal Transplant Foundation Inc. $1,554 10 payments
  6. Solventum Corporation $1,269 8 payments
  7. Mentor Worldwide LLC $446 15 payments
  8. Innovation Technologies Inc $418 4 payments
  9. Vertex Pharmaceuticals Incorporated $379 7 payments
  10. Motiva USA, LLC $328 8 payments
  11. Other $1,607 48 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $124,363 29 payments
  2. Travel and Lodging $31,946 50 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $10,300 2 payments
  4. Food and Beverage $8,433 198 payments
  5. Debt forgiveness $3,078 1 payment
Products named General payments · program years 2019–2025
  1. Integra Recon-Skin And Wound $121,040 112 payments
  2. Integra Recon-Skin And Wound $120,905 111 payments
  3. IDRT $17,586 23 payments
  4. FLOWABLE $17,463 22 payments
  5. INTEGRA WOUND MATRIX (IWM) $17,463 22 payments
  6. BILAYER WOUND MATRIX (BWM) $17,463 22 payments
  7. ADVANCED WOUND CARE $10,127 2 payments
  8. INTEGRA WOUND MATRIX (THIN) $9,798 6 payments
  9. INTEGRA MESHED BILAYER WOUND MATRIX $9,798 6 payments
  10. INTEGRA DERMAL REGENERATION TEMPLATE $7,842 82 payments
  11. Other $39,604 327 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 62 billing codes

Paid by Medicare

$51,155

Medicare's payments for the services billed

Medicare patients

42

Average age 70

Services billed

400

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 71%
Arthritis 60%
Diabetes 33%
Chronic kidney disease 33%
Depression 31%
Cancer 29%
Heart failure 26%
Ischemic heart disease 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
DALVANCE
$12 — —
TEFLARO
$12 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

280 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record